193 related articles for article (PubMed ID: 26496339)
21. Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience.
Moschini M; Karnes RJ; Sharma V; Gandaglia G; Fossati N; Dell'Oglio P; Cucchiara V; Capogrosso P; Shariat SF; Damiano R; Salonia A; Montorsi F; Briganti A; Gallina A; Colombo R
Eur J Surg Oncol; 2016 May; 42(5):735-43. PubMed ID: 26927300
[TBL] [Abstract][Full Text] [Related]
22. Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni LB; Joshi SS; Kissick H; Ogan K; Harris WB; Carthon BC; Kucuk O; Master VA; Bilen MA
Oncologist; 2021 May; 26(5):397-405. PubMed ID: 33634507
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of serum lactate dehydrogenase in patients undergoing radical cystectomy for bladder cancer.
Su S; Liu L; Sun C; Yang L; Nie Y; Chen Y; Zhang J; Li S
Urol Oncol; 2020 Nov; 38(11):852.e1-852.e9. PubMed ID: 32624424
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma.
Cho DS; Kim SI; Choo SH; Jang SH; Ahn HS; Kim SJ
Scand J Urol; 2016 Jun; 50(3):186-91. PubMed ID: 26878156
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of preoperative hydronephrosis in patients with bladder cancer undergoing radical cystectomy: A meta-analysis.
Zhu Z; Zhao J; Li Y; Pang C; Zhu Z; Zhang X
PLoS One; 2019; 14(9):e0222223. PubMed ID: 31513614
[TBL] [Abstract][Full Text] [Related]
26. Analysis of open and intracorporeal robotic assisted radical cystectomy shows no significant difference in recurrence patterns and oncological outcomes.
Tan WS; Sridhar A; Ellis G; Lamb B; Goldstraw M; Nathan S; Hines J; Cathcart P; Briggs T; Kelly J
Urol Oncol; 2016 Jun; 34(6):257.e1-9. PubMed ID: 26968561
[TBL] [Abstract][Full Text] [Related]
27. Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series.
Bruins HM; Arends TJ; Pelkman M; Hulsbergen-van de Kaa CA; van der Heijden AG; Witjes JA
Clin Genitourin Cancer; 2014 Jun; 12(3):190-5. PubMed ID: 24332508
[TBL] [Abstract][Full Text] [Related]
28. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
Bolenz C; Herrmann E; Bastian PJ; Michel MS; Wülfing C; Tiemann A; Buchner A; Stief CG; Fritsche HM; Burger M; Wieland WF; Höfner T; Haferkamp A; Hohenfellner M; Müller SC; Ströbel P; Trojan L
BJU Int; 2010 Aug; 106(4):493-9. PubMed ID: 20067452
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration.
Soria F; Giordano A; D'Andrea D; Moschini M; Rouprêt M; Margulis V; Karakiewicz PI; Briganti A; Bensalah K; Mathieu R; Chlosta P; Babjuk M; Glybochko PV; Enikeev DV; Remzi M; Gust K; Gontero P; Shariat SF
Urol Oncol; 2020 Jun; 38(6):602.e11-602.e19. PubMed ID: 32037197
[TBL] [Abstract][Full Text] [Related]
30. Patterns of local recurrence after radical cystectomy in a contemporary series of patients with muscle-invasive bladder cancer.
Cornu JN; Neuzillet Y; Hervé JM; Yonneau L; Botto H; Lebret T
World J Urol; 2012 Dec; 30(6):821-6. PubMed ID: 22940772
[TBL] [Abstract][Full Text] [Related]
31. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
Evers PD; Logan JE; Sills V; Chin AI
World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
[TBL] [Abstract][Full Text] [Related]
32. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
34. Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy.
Ferro M; Tătaru OS; Musi G; Lucarelli G; Abu Farhan AR; Cantiello F; Damiano R; Hurle R; Contieri R; Busetto GM; Carrieri G; Cormio L; Del Giudice F; Sciarra A; Perdonà S; Borghesi M; Terrone C; La Civita E; Bove P; Autorino R; Muto M; Crisan N; Marchioni M; Schips L; Soria F; Terracciano D; Papalia R; Crocetto F; Barone B; Russo GI; Luzzago S; Ludovico GM; Vartolomei MD; Mistretta FA; Mirone V; de Cobelli O
Diagnostics (Basel); 2022 Feb; 12(3):. PubMed ID: 35328139
[TBL] [Abstract][Full Text] [Related]
35. Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity.
Tarin TV; Power NE; Ehdaie B; Sfakianos JP; Silberstein JL; Savage CJ; Sjoberg D; Dalbagni G; Bochner BH
Eur Urol; 2012 May; 61(5):1025-30. PubMed ID: 22342773
[TBL] [Abstract][Full Text] [Related]
36. The impact of carcinoma in situ in ureteral margins during radical cystectomy: A case-controlled study.
Kerroumi S; Neuzillet Y; Soorojebally Y; Radulescu C; Talhi R; Taleb S; Herve CJ; Rouanne M; Abdou A; Bosset P; Bazzi A; Yousfi MJ; Lebret T
Urol Oncol; 2021 Aug; 39(8):497.e1-497.e8. PubMed ID: 33579627
[TBL] [Abstract][Full Text] [Related]
37. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
[TBL] [Abstract][Full Text] [Related]
38. Long-term oncologic outcomes of robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (ICUD): a multi-center study.
Brassetti A; Cacciamani G; Anceschi U; Ferriero M; Tuderti G; Miranda G; Mastroianni R; Desai M; Aron M; Gill I; Gallucci M; Simone G
World J Urol; 2020 Apr; 38(4):837-843. PubMed ID: 31190152
[TBL] [Abstract][Full Text] [Related]
39. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
[TBL] [Abstract][Full Text] [Related]
40. De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study.
Yuk HD; Jeong CW; Kwak C; Kim HH; Ku JH
Dis Markers; 2019; 2019():6702964. PubMed ID: 31534562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
